Walgreens Boots Alliance price target lowered to $46 from $47 at Deutsche Bank

Deutsche Bank lowered the firm’s price target on Walgreens Boots Alliance to $46 from $47 and keeps a Buy rating on the shares. The company’s core fiscal Q2 results "were mixed," the analyst tells investors in a research note. Walgreens maintained its guidance for 2023, with the company now needing to deliver on the promised inflection both in the U.S. pharmacy business as well as the "rapidly maturing" Health segment to deliver on its second half promises, the analyst tells investors in a research note.